[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.122.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 19, 1954

FRANCE

JAMA. 1954;155(8):771-772. doi:10.1001/jama.1954.03690260063022

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Mammary Cancer and Uterine Fibroids.  —A study of the association of mammary cancer and uterine fibroids has been carried on by Funck-Grentano and J. De Brux. Such an association is not common. The fact that the same pathogenic factors can produce both conditions should direct attention to those factors of endocrine origin and to clinical and therapeutic applications. Experimentally, the estrogens can produce mammary cancer in mice and fibrous tumors in guinea pig and rabbit uteri. Mammary cancer is frequently encountered in a woman who has shown biological, as well as clinical, signs of hyperfolliculinism. In 1948, Rudler reported on a 35-year-old woman in whom these two conditions developed after intensive treatment with estrone (Folliculin). In men, mammary cancer has been observed after treatment with large doses of estrogens for cancer of the prostate. The efficacy of therapy with androgens in woman is further evidence of the causal part played

First Page Preview View Large
First page PDF preview
First page PDF preview
×